You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Intermediate Uveitis

Showing 1 - 25 of 2,268
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Uveitis, Posterior, Uveitis, Anterior, Uveitis, Intermediate Trial in Waltham (Ixekizumab Prefilled Syringe)

Recruiting
  • Uveitis, Posterior
  • +3 more
  • Ixekizumab Prefilled Syringe
  • Waltham, Massachusetts
    Massachusetts Eye Research and Surgery Institution
Oct 11, 2023

Non-infectious Uveitis Trial (care strategy)

Not yet recruiting
  • Non-infectious Uveitis
  • care strategy
  • (no location specified)
Jun 26, 2023

Uveitis Posterior Non-Infectious, Uveitis, Intermediate, Noninfectious Panuveitis Trial in Waltham, Erie (ESK-001)

Recruiting
  • Uveitis Posterior Non-Infectious
  • +2 more
  • Waltham, Massachusetts
  • +1 more
Jul 18, 2023

Uveitis, Posterior, Uveitis, Intermediate, Panuveitis Trial (Ozurdex 0.7mg Ophthalmic Implant, Prednisone)

Recruiting
  • Uveitis, Posterior
  • +2 more
  • Ottawa, Ontario, Canada
    Ottawa Hospital Research Institute - Vision Research Centre
Dec 14, 2022

Uveitis, Uveitis, Posterior, Uveitis, Intermediate Trial in Waltham (Sham Injector, FAI Insert)

Active, not recruiting
  • Uveitis
  • +2 more
  • Sham Injector
  • FAI Insert
  • Waltham, Massachusetts
    EyePoint Study Site
Dec 20, 2022

Uveitis Trial (adalimumab)

Completed
Has Results
  • Uveitis
  • (no location specified)
Jul 8, 2021

Uveitis, Uveitis, Posterior, Uveitis, Anterior Trial in Plano (Yutiq 0.18 MG Drug Implant, Sham Injection)

Not yet recruiting
  • Uveitis
  • +3 more
  • Yutiq 0.18 MG Drug Implant
  • Sham Injection
  • Plano, Texas
    Texas Retina Associates
Aug 3, 2022

Retinal Nerve Fiber Layer Thickness During Uncomplicated

Completed
  • Anterior Uveitis
  • Intermediate Uveitis
    • Québec, Canada
      Centre universitaire d'ophtalmologie, Hôpital du Saint-Sacrement
    Jan 25, 2021

    Uveitis Trial (Adalimumab, Prednisone, Placebo)

    Completed
    Has Results
    • Uveitis
    • (no location specified)
    Jul 2, 2021

    Uveitis Trial in United States (Izokibep, Placebo)

    Recruiting
    • Uveitis
    • Phoenix, Arizona
    • +20 more
    Jan 11, 2023

    Non-infectious Intermediate Posterior- or Pan-uveitis Trial in China (Adalimumab)

    Recruiting
    • Non-infectious Intermediate Posterior- or Pan-uveitis
    • Beijing, Beijing, China
    • +7 more
    Dec 6, 2022

    Uveitis Trial in United States (Izokibep, Prednisone/Prednisolone)

    Active, not recruiting
    • Uveitis
    • Los Angeles, California
    • +3 more
    Jul 18, 2022

    Uveitis Trial (Adalimumab, Prednisone, Placebo)

    Completed
    Has Results
    • Uveitis
    • Adalimumab
    • +2 more
    • (no location specified)
    Jul 2, 2021

    Uveitis, Intermediate Uveitis, Posterior Uveitis Trial in Palo Alto (Intravitreal injection 440mcg, Intravitreal injection of

    Recruiting
    • Uveitis
    • +3 more
    • Intravitreal injection 440mcg
    • Intravitreal injection of sirolimus 880mcg
    • Palo Alto, California
      Stanford University
    May 5, 2021

    Uveitis, Posterior, Uveitis, Intermediate, Panuveitis Trial in United States (Acthar Gel)

    Terminated
    Has Results
    • Uveitis, Posterior
    • +2 more
    • Acthar Gel
    • Clearwater, Florida
    • +7 more
    Jul 12, 2021

    Uveitis, Intermediate Uveitis, Posterior Uveitis Trial in Chicago, Omaha, Cleveland (triamcinolone acetonide (Triesence®))

    Completed
    Has Results
    • Uveitis
    • +4 more
    • triamcinolone acetonide (Triesence®)
    • Chicago, Illinois
    • +2 more
    Feb 17, 2021

    Non-infectious Uveitis Trial in France, United Kingdom (pEYS606)

    Completed
    • Non-infectious Uveitis
    • pEYS606
    • Grenoble, France
    • +3 more
    Mar 9, 2022

    Uveitis, Uveitis, Posterior, Uveitis, Anterior Trial in United States (4 mg CLS-TA Suprachoriodal Injection)

    Completed
    Has Results
    • Uveitis
    • +4 more
    • 4 mg CLS-TA Suprachoriodal Injection
    • Phoenix, Arizona
    • +9 more
    Jun 18, 2021

    Non-infectious Intermediate Uveitis, Non-infectious Posterior Uveitis, Non-infectious Panuveitis Trial in United Kingdom, United

    Completed
    Has Results
    • Non-infectious Intermediate Uveitis
    • +2 more
    • Golden, Colorado
    • +7 more
    Dec 9, 2020

    Non-infectious Uveitis Who Participated in CLS1001-301

    Completed
    Has Results
    • Uveitis
    • +4 more
    • 4 mg CLS-TA Suprachoriodal Injection
    • Sham procedure
    • Phoenix, Arizona
    • +15 more
    May 13, 2021

    Uveitis, Macular Edema, Uveitis, Posterior Trial in United States (4 mg CLS-TA, 0.8 mg CLS-TA)

    Completed
    Has Results
    • Uveitis
    • +5 more
    • 4 mg CLS-TA
    • 0.8 mg CLS-TA
    • Miami, Florida
    • +10 more
    Jan 18, 2021

    Uveitis, Posterior Uveitis, Panuveitis Trial in United States (AEB071)

    Completed
    • Uveitis
    • +2 more
    • Los Angeles, California
    • +12 more
    Dec 15, 2020

    Uveitis, Uveitis, Posterior, Uveitis, Anterior Trial in India, Israel, United States (4mg CLS-TA Suprachoriodal Injection, Sham

    Completed
    Has Results
    • Uveitis
    • +4 more
    • 4mg CLS-TA Suprachoriodal Injection
    • Sham Procedure
    • Phoenix, Arizona
    • +63 more
    May 4, 2021

    Posterior Uveitis, Intermediate Uveitis, Panuveitis Trial in India (Sham Injection, FAI Insert)

    Completed
    Has Results
    • Posterior Uveitis
    • +2 more
    • Sham Injection
    • FAI Insert
    • Hyderabad, Andhra Pradesh, India
    • +14 more
    Jul 10, 2020

    Uveitis Trial in Worldwide (AIN457, Placebo)

    Withdrawn
    • Uveitis
    • AIN457
    • Placebo
    • Arlington, Texas
    • +10 more
    Sep 24, 2020